33 results on '"Ishigatsubo Y"'
Search Results
2. THU0589 Infliximab Therapy for Neuro-, Vascular, and Intestinal Behçet's Disease: Efficacy, Safety, and Pharmacokinetics in A Multicenter Prospective Study
3. SAT0620 Wrist PD Signal Detected by Ultrasonography Relates to Joint Destruction in Rheumatoid Arthritis Under Biologics Therapy in Real World: Table 1.
4. SAT0214 Comparison of Response to Tocilizumab Between Biologic-Naïve Patients and Non-Responder to TNF Inhibitor Failure in Rheumatoid Arthritis: A Retrospective Study Using the Y-Curd Registry
5. FRI0561 The Availability of On-Demand Ultrasonography Assessment in the Most Affected Joint for Management of RA Patients in Daily Practice
6. FRI0610 Ultrasonograpic Assessment Covers a Pitfal of Physycal Examination in the Ankle Joints in Patients with Rheumatoid Arthritis: Table1.
7. FRI0269 Immunogenecity of Infliximab is Responsible for Reduced Efficacy and Infusion Reaction in Behçet's Disease with Uveitis
8. AB0278 Early Termination of the First Biological Disease-Modifying Antirheumatic Drugs Therapy Leads to Radiological Progression in Patients with Rheumatoid Arthritis, Irrespective of Subsequent Therapies
9. AB0510 Predicting Factors of Unfavorable Clinical Outcome in Lupus Nephritis
10. OP0052 Prospective Evaluation of 18F-FDG and 18F-Naf Pet/Ct: Imaging Analysis of Inflammation and Bone Metabolism in Rheumatoid Arthritis
11. SAT0263 Comparison between TOCILIZUMAB and Alternatve TNF Inhibitor as A Second Line following TNF Inhibitor Failure in Patients with Rheumatoid Arthritis
12. AB0050 Irf8 Promotes TH17 Differentiation via Activation of Integrin-Mediated Tgfbeta Signaling in Neuroinflammation
13. FRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48)
14. AB0511 The analysis of prognostic factors in patients with inflammatory myopathies and amyopathic dermatomiositis complicated with interstitial lung disease
15. THU0408 Deep inspiratory breath hold PET/CT is useful for monitoring of activity in rheumatic disease associated lung interstitial pneumonitis
16. FRI0476 Relative fdg accumulation of the aortic wall lesions to aortic blood pool in 18f-fdg-pet and pet/ct is a useful parameter for assessing the disease activity of takayasu arteritis
17. AB0774 Comparative clinical characteristics of cyclosporine-related and cyclosporine-unrelated acute neurological events in behcet’s disease
18. AB0449 Radiographic change and time-course change in cytokine levels of rheumatoid arthritis patients on etanercept treatment
19. SAT0403 Ultrasound in the diagnosis of rheumatoid arthritis
20. SAT0520 Ultrasonography is Useful for Predicting Boolean Remission after Achieving DAS28-Based Clinical Remission of Rheumatoid Arthritis
21. AB1225 Treatment with TNF blockers are effective and safe in BD patients with uveitis
22. THU0211 Gastrointestinal manifestations of behçet’s disease in japan: A study of 43 patients
23. FRI0065 Residual power doppler signals during clinical remission determine joint prognosis in rheumatoid arthritis
24. SAT0519 Total Power Doppler Score-8 is a Useful Diagnostic Marker of Musculoskeletal Ultrasonography for Screening and Activity Measurement of Rheumatoid Arthritis
25. SAT0159 Clinical Features of Japanese Patients with Vasculo- BehÇEt’S Disease: A Multicenter Study by BehÇEt’S Disease Research Committee, MHLW
26. AB0732 New programs of automatic acquisition of pd gain and automatic extraction of appropriate image in msus
27. AB0480 Colchicine reduces relapse of acute neurological attacks in behcet’s disease
28. THU0171 Therapeutic response of lupus nephritis based on pathological findings in yokohama city university hospital
29. THU0448 The Profile of Musculoskeletal Ultrasonography in Patients with Adult Onset Still Disease.
30. P2-146 Epidemiological and clinical characteristics of BehCet's disease in Japan, by years after disease onset, using a clinical database on patients receiving financial aid for treatment
31. Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study
32. Central nervous system toxicity related to FK506 in patients with Behcet's disease.
33. Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.